{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T03:59:06Z","timestamp":1790222346139,"version":"4.1.0"},"reference-count":125,"publisher":"Informa UK Limited","issue":"1","license":[{"start":{"date-parts":[[2024,9,23]],"date-time":"2024-09-23T00:00:00Z","timestamp":1727049600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"Instituto de Investigaci\u00f3n Biom\u00e9dica de Lleida, Fundaci\u00f3n Dr Pifarr\u00e9"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Review of Vaccines"],"published-print":{"date-parts":[[2024,12,31]]},"DOI":"10.1080\/14760584.2024.2401839","type":"journal-article","created":{"date-parts":[[2024,9,11]],"date-time":"2024-09-11T09:57:13Z","timestamp":1726048633000},"page":"887-910","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":5,"title":["Vaccination strategies for patients under monoclonal antibody and other biological treatments: an updated comprehensive review based on EMA authorisations to January 2024"],"prefix":"10.1080","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6159-6037","authenticated-orcid":false,"given":"Mario","family":"Rivera-Izquierdo","sequence":"first","affiliation":[{"name":"Hospital Universitario San Cecilio","place":["Granada, Spain"]},{"name":"University of Granada","place":["Granada, Spain"]},{"name":"Instituto de investigaci\u00f3n biosanitaria de Granada (ibs.GRANADA)","place":["Granada, Spain"]},{"name":"CIBER de Epidemiolog\u00eda y Salud P\u00fablica (CIBERESP)","place":["Madrid, Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arturo","family":"Morales-Portillo","sequence":"additional","affiliation":[{"name":"Hospital Universitari Arnau de Vilanova","place":["Lleida, Spain"]},{"name":"Institut de Recerca Biom\u00e8dica de Lleida (IRBLleida)","place":["Lleida, Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inmaculada","family":"Guerrero-Fern\u00e1ndez de Alba","sequence":"additional","affiliation":[{"name":"Hospital Universitario San Cecilio","place":["Granada, Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8257-4304","authenticated-orcid":false,"given":"Nicol\u00e1s Francisco","family":"Fern\u00e1ndez-Mart\u00ednez","sequence":"additional","affiliation":[{"name":"Instituto de investigaci\u00f3n biosanitaria de Granada (ibs.GRANADA)","place":["Granada, Spain"]},{"name":"CIBER de Epidemiolog\u00eda y Salud P\u00fablica (CIBERESP)","place":["Madrid, Spain"]},{"name":"Andalusian School of Public Health (EASP)","place":["Granada, Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joan Antoni","family":"Schoenenberger-Arnaiz","sequence":"additional","affiliation":[{"name":"Hospital Universitari Arnau de Vilanova","place":["Lleida, Spain"]},{"name":"Institut de Recerca Biom\u00e8dica de Lleida (IRBLleida)","place":["Lleida, Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6925-8363","authenticated-orcid":false,"given":"Jos\u00e9 Luis","family":"Barranco-Quintana","sequence":"additional","affiliation":[{"name":"Hospital Universitario Reina Sof\u00eda","place":["Spain"]},{"name":"Maimonides Biomedical Research Institute of Cordoba (IMIBIC)","place":["Spain"]},{"name":"Expert Committee on Andalusian Vaccine Plan, Consejer\u00eda de Salud y Familias","place":["Junta de Andaluc\u00eda, Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen","family":"Valero-Ubierna","sequence":"additional","affiliation":[{"name":"Hospital Universitario San Cecilio","place":["Granada, Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2024,9,23]]},"reference":[{"key":"e_1_3_7_3_1","doi-asserted-by":"publisher","DOI":"10.1002\/prp2.535"},{"key":"e_1_3_7_4_1","doi-asserted-by":"publisher","DOI":"10.7861\/clinmedicine.17-3-220"},{"key":"e_1_3_7_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.coph.2012.08.001"},{"key":"e_1_3_7_6_1","doi-asserted-by":"publisher","DOI":"10.1007\/s13238-010-0052-8"},{"key":"e_1_3_7_7_1","unstructured":"European Medicines Agency (EMA). European public assessment report. [cited 2024 Jan 1]. Available from: http:\/\/www.ema.europa.eu\/en\/glossary\/european-public-assessment-report"},{"key":"e_1_3_7_8_1","doi-asserted-by":"publisher","DOI":"10.1080\/14760584.2020.1800462"},{"key":"e_1_3_7_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.msard.2022.104486"},{"key":"e_1_3_7_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ekir.2021.03.876"},{"key":"e_1_3_7_11_1","doi-asserted-by":"publisher","DOI":"10.1080\/21505594.2022.2146380"},{"key":"e_1_3_7_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2023.06.021"},{"key":"e_1_3_7_13_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-39292-w"},{"key":"e_1_3_7_14_1","unstructured":"European Medicines Agency (EMA). European public assessment report. [cited 2024 Jan 1]. Available from: https:\/\/www.ema.europa.eu\/en\/glossary\/european-public-assessment-report"},{"key":"e_1_3_7_15_1","unstructured":"Animal Cell Technology Industrial Platform (ACTIP). [cited 2024 Jan 1]. Available from: https:\/\/www.actip.org\/"},{"key":"e_1_3_7_16_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.21386"},{"key":"e_1_3_7_17_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.22504"},{"key":"e_1_3_7_18_1","doi-asserted-by":"publisher","DOI":"10.1080\/14740338.2021.1946513"},{"key":"e_1_3_7_19_1","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.00035-19"},{"key":"e_1_3_7_20_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-021-10744-x"},{"key":"e_1_3_7_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmi.2018.02.003"},{"key":"e_1_3_7_22_1","doi-asserted-by":"publisher","DOI":"10.1080\/13696998.2023.2242169"},{"key":"e_1_3_7_23_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2116620"},{"key":"e_1_3_7_24_1","unstructured":"U.S. Food and Drug Administration (FDA). FDA announces evusheld is not currently authorized for emergency use in the U.S. [cited 2024 Jan 1]. Available from: https:\/\/www.fda.gov\/drugs\/drug-safety-and-availability\/fda-announces-evusheld-not-currently-authorized-emergency-use-us"},{"key":"e_1_3_7_25_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2207566"},{"key":"e_1_3_7_26_1","unstructured":"Consejer\u00eda de Salud y Consumo Direcci\u00f3n General de Salud P\u00fablica y Ordenaci\u00f3n Farmac\u00e9utica Junta de Andaluc\u00eda. Programa de prevenci\u00f3n de infecci\u00f3n VRS con Nirsevimab. Andaluc\u00eda campa\u00f1a 2023-2024 [RSV infection prevention program with Nirsevimab. Andalusia campaign 2023-2024]. [cited 2024 Jan 1]. Available from: https:\/\/www.andavac.es\/wp-content\/uploads\/instrucciones\/Instruccion_DGSPyOF-9-2023_Nirsevimab_Andalucia_2023-2024.pdf"},{"key":"e_1_3_7_27_1","doi-asserted-by":"publisher","DOI":"10.2807\/1560-7917.ES.2023.28.49.2300606"},{"key":"e_1_3_7_28_1","unstructured":"Centers for Disease Control and Prevention (CDC). Advisory Committee on Immunization Practices (ACIP). General best practice guidelines for immunization: best practices guidance. Altered immunocompetence. [cited 2024 Jan 1]. Available from: https:\/\/www.cdc.gov\/vaccines\/hcp\/acip-recs\/general-recs\/index.html"},{"key":"e_1_3_7_29_1","unstructured":"Centers for Disease Control and Prevention (CDC). Advisory Committee on Immunization Practices (ACIP). Immunization schedules. [cited 2024 Jan 1]. Available from: https:\/\/www.cdc.gov\/vaccines\/schedules\/hcp\/adult.html"},{"key":"e_1_3_7_30_1","unstructured":"Infectious Diseases Society of America (IDSA). Clinical practice guideline for vaccination of the immunocompromised host. [cited 2024 Jan 1]. Available from: https:\/\/www.idsociety.org\/practice-guideline\/vaccination-of-the-immunocompromised-host\/"},{"key":"e_1_3_7_31_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cit816"},{"key":"e_1_3_7_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2023.101965"},{"key":"e_1_3_7_33_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2017.03.011"},{"key":"e_1_3_7_34_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2018.01.061"},{"key":"e_1_3_7_35_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00393-020-00891-3"},{"key":"e_1_3_7_36_1","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.161407"},{"key":"e_1_3_7_37_1","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines11111680"},{"key":"e_1_3_7_38_1","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.111587"},{"key":"e_1_3_7_39_1","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.130945"},{"key":"e_1_3_7_40_1","doi-asserted-by":"publisher","DOI":"10.7224\/1537-2073.2016-026"},{"key":"e_1_3_7_41_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2014.03.035"},{"key":"e_1_3_7_42_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40120-023-00448-x"},{"key":"e_1_3_7_43_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1601277"},{"key":"e_1_3_7_44_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10875-012-9813-x"},{"key":"e_1_3_7_45_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.25033"},{"key":"e_1_3_7_46_1","doi-asserted-by":"publisher","DOI":"10.3109\/0284186X.2014.914243"},{"key":"e_1_3_7_47_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2022.48664"},{"key":"e_1_3_7_48_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2022.109144"},{"key":"e_1_3_7_49_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2013-204427"},{"key":"e_1_3_7_50_1","doi-asserted-by":"publisher","DOI":"10.3109\/14397595.2013.843743"},{"key":"e_1_3_7_51_1","doi-asserted-by":"publisher","DOI":"10.1177\/13524585221151124"},{"issue":"10","key":"e_1_3_7_52_1","first-page":"1122","article-title":"Immune response to pneumococcus and tetanus toxoid in patients with moderate-to-severe psoriasis following long-term ustekinumab use","volume":"12","author":"Brodmerkel C","year":"2013","unstructured":"Brodmerkel C, Wadman E, Langley RG, et al. Immune response to pneumococcus and tetanus toxoid in patients with moderate-to-severe psoriasis following long-term ustekinumab use. J Drugs Dermatol. 2013;12(10):1122\u20131129.","journal-title":"J Drugs Dermatol"},{"key":"e_1_3_7_53_1","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2014-307127"},{"key":"e_1_3_7_54_1","first-page":"74","volume-title":"Red Book: 2015 Report of the Committee on Infectious Diseases","author":"American Academy of Pediatrics","year":"2015","unstructured":"American Academy of Pediatrics. Committee on Infectious Diseases. Immunization in special clinical circumstances: Immunization in immunocompromised children. In: Kimberlin DW, Brady MT, Jackson MA, Long SS, editors. Red Book: 2015 Report of the Committee on Infectious Diseases. Elk Grove Village, IL: American Academy of Pediatrics; 2015. p. 74\u201389."},{"key":"e_1_3_7_55_1","unstructured":"Asociaci\u00f3n Espa\u00f1ola de Pediatr\u00eda (AEP). Comit\u00e9 Asesor de Vacunas. Vacunaci\u00f3n en ni\u00f1os inmunodeprimidos o con tratamiento inmunosupresor. Manual de Vacunas en l\u00ednea de la AEP. Cap\u00edtulo 14. [Spanish Pediatrics Association (AEP). Vaccine Advisory Committee. Vaccination in immunosuppressed children or children under immunosuppressive therapy. AEP Online immunization manual. Chapter 14. [cited 2024 Jan 1]. Available from: http:\/\/vacunasaep.org\/print\/documentos\/manual\/cap-14"},{"key":"e_1_3_7_56_1","volume-title":"Immunisation against infectious diseases: immunisation of individuals with underlying medical conditions","author":"Public Health England","year":"2016","unstructured":"Public Health England. Immunisation against infectious diseases: immunisation of individuals with underlying medical conditions. Salisbury: The Green Book. The Stationary Office; 2016."},{"key":"e_1_3_7_57_1","unstructured":"Australian Technical Advisory Group on Immunisation (ATAGI). The Australian immunization handbook 10th ed (2017 update). Canberra: Australian Government Department of Health. Part 3.3.3 Vaccination of immunocompromised persons; 2017 [cited 2024 Jan 1]. Available from: http:\/\/www.immunise.health.gov.au\/internet\/immunise\/publishing.nsf\/Content\/Handbook10-home~handbook10part3~handbook10-3-3#3-3-3"},{"key":"e_1_3_7_58_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cit816"},{"key":"e_1_3_7_59_1","unstructured":"Ministerio de Sanidad Consumo y Bienestar Social. Vacunaci\u00f3n en grupos de riesgo de todas las edades y en determinadas situaciones del programa y registro de vacunaciones 2018 [Spanish Ministry of Health Consumer Affairs and Social Welfare. Vaccination of risk groups of all ages and in specific circumstances program and registry of vaccinations 2018]. [cited 2024 Jan 1]. Available from: https:\/\/www.mscbs.gob.es\/profesionales\/saludPublica\/prevPromocion\/vacunaciones\/VacGruposRiesgo\/docs\/VacGruposRiesgo_todas_las_edades.pdf"},{"key":"e_1_3_7_60_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0147856"},{"key":"e_1_3_7_61_1","doi-asserted-by":"publisher","DOI":"10.1007\/s13311-022-01224-9"},{"key":"e_1_3_7_62_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.msard.2019.04.004"},{"key":"e_1_3_7_63_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.medcli.2019.02.003"},{"key":"e_1_3_7_64_1","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2018.1445446"},{"key":"e_1_3_7_65_1","doi-asserted-by":"publisher","DOI":"10.1038\/bmt.2017.24"},{"key":"e_1_3_7_66_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-6143.2007.01982.x"},{"key":"e_1_3_7_67_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciw855"},{"key":"e_1_3_7_68_1","doi-asserted-by":"publisher","DOI":"10.1080\/03007995.2017.1329140"},{"key":"e_1_3_7_69_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2020.09.004"},{"key":"e_1_3_7_70_1","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jis487"},{"key":"e_1_3_7_71_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.01400"},{"key":"e_1_3_7_72_1","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2018.1538618"},{"key":"e_1_3_7_73_1","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2017-000484"},{"key":"e_1_3_7_74_1","doi-asserted-by":"publisher","DOI":"10.1002\/acr.22246"},{"key":"e_1_3_7_75_1","doi-asserted-by":"publisher","DOI":"10.1002\/ibd.21800"},{"key":"e_1_3_7_76_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2018.07.039"},{"key":"e_1_3_7_77_1","doi-asserted-by":"publisher","DOI":"10.1177\/0961203317695465"},{"key":"e_1_3_7_78_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-022-01733-z"},{"key":"e_1_3_7_79_1","doi-asserted-by":"publisher","DOI":"10.14745\/ccdr.v49i23a08"},{"issue":"11","key":"e_1_3_7_80_1","first-page":"678","article-title":"Apexxnar\u00ae, vaccin anti-pneumococcique conjugu\u00e9 avec 20 s\u00e9rotypes [Apexxnar\u00ae, 20-valent pneumococcal conjugate vaccine]","volume":"77","author":"Scheen AJ","year":"2022","unstructured":"Scheen AJ, Louis R, Moutschen M. Apexxnar\u00ae, vaccin anti-pneumococcique conjugu\u00e9 avec 20 s\u00e9rotypes [Apexxnar\u00ae, 20-valent pneumococcal conjugate vaccine]. Rev Med Liege. 2022;77(11):678\u2013683.","journal-title":"Rev Med Liege"},{"key":"e_1_3_7_81_1","doi-asserted-by":"publisher","DOI":"10.1080\/14760584.2023.2273892"},{"key":"e_1_3_7_82_1","unstructured":"Consejer\u00eda de Salud y Consumo Direcci\u00f3n General de Salud P\u00fablica Junta de Andaluc\u00eda. Programa de vacunaci\u00f3n frente a neumococo en Andaluc\u00eda 2023. [Pneumococcal vaccination program in Andalusia 2023]. [cited 2024 Jan 1]. Available from: https:\/\/www.andavac.es\/wp-content\/uploads\/instrucciones\/Instruccion_Vacunacion_Neumococo_Andalucia.pdf"},{"key":"e_1_3_7_83_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciad349"},{"key":"e_1_3_7_84_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2023.12.075"},{"key":"e_1_3_7_85_1","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2023.2191577"},{"key":"e_1_3_7_86_1","doi-asserted-by":"publisher","DOI":"10.1080\/14760584.2018.1484286"},{"key":"e_1_3_7_87_1","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2016.1174354"},{"key":"e_1_3_7_88_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0264-410X(97)00254-5"},{"key":"e_1_3_7_89_1","doi-asserted-by":"publisher","DOI":"10.1097\/RHU.0000000000000877"},{"key":"e_1_3_7_90_1","doi-asserted-by":"publisher","DOI":"10.4103\/0256-4947.87091"},{"key":"e_1_3_7_91_1","doi-asserted-by":"publisher","DOI":"10.1080\/14760584.2017.1338568"},{"key":"e_1_3_7_92_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.anai.2018.03.017"},{"key":"e_1_3_7_93_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2022.12.009"},{"key":"e_1_3_7_94_1","doi-asserted-by":"publisher","DOI":"10.1590\/s0004-2803.201900000-77"},{"key":"e_1_3_7_95_1","doi-asserted-by":"publisher","DOI":"10.1002\/lt.20674"},{"key":"e_1_3_7_96_1","doi-asserted-by":"publisher","DOI":"10.4254\/wjh.v7.i24.2503"},{"key":"e_1_3_7_97_1","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jix178"},{"key":"e_1_3_7_98_1","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiw606"},{"key":"e_1_3_7_99_1","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofy174"},{"key":"e_1_3_7_100_1","doi-asserted-by":"publisher","DOI":"10.1086\/587063"},{"key":"e_1_3_7_101_1","doi-asserted-by":"publisher","DOI":"10.4254\/wjh.v9.i13.613"},{"key":"e_1_3_7_102_1","doi-asserted-by":"publisher","DOI":"10.1177\/1078155219837342"},{"key":"e_1_3_7_103_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.tmaid.2017.12.004"},{"key":"e_1_3_7_104_1","unstructured":"Government of Canada. Update on the recommended use of hepatitis a vaccine. An advisory committee statement (ACS) national advisory committee on immunization (NACI). [cited 2024 Jan 1]. Available from: https:\/\/www.canada.ca\/en\/public-health\/services\/publications\/healthy-living\/update-recommended-use-hepatitis-vaccine.html"},{"key":"e_1_3_7_105_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2013.06.046"},{"key":"e_1_3_7_106_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.39480"},{"key":"e_1_3_7_107_1","doi-asserted-by":"publisher","DOI":"10.14745\/ccdr.v43i06a04"},{"key":"e_1_3_7_108_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.nrl.2019.11.003"},{"key":"e_1_3_7_109_1","doi-asserted-by":"publisher","DOI":"10.1586\/14760584.2015.1051470"},{"key":"e_1_3_7_110_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2019.9053"},{"key":"e_1_3_7_111_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.31909"},{"key":"e_1_3_7_112_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2016.10.055"},{"key":"e_1_3_7_113_1","doi-asserted-by":"publisher","DOI":"10.1021\/jm401490p"},{"key":"e_1_3_7_114_1","unstructured":"Consejer\u00eda de Salud y Consumo Direcci\u00f3n General de Salud P\u00fablica Junta de Andaluc\u00eda. Programa de vacunaci\u00f3n frente a herpes z\u00f3ster en Andaluc\u00eda 2023. [Vaccination program against herpes zoster in Andalusia 2023]. [cited 2024 Jan 1]. Available from: https:\/\/www.andavac.es\/wp-content\/uploads\/instrucciones\/Instruccion_Vacunacion_Herpes_Zoster_Andalucia.pdf"},{"key":"e_1_3_7_115_1","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2023.2278362"},{"key":"e_1_3_7_116_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.978203"},{"key":"e_1_3_7_117_1","unstructured":"Ministerio de Sanidad Gobierno de Espa\u00f1a. Recomendaciones de vacunaci\u00f3n frente a herpes z\u00f3ster 25 de marzo de 2021 [Herpes zoster vaccine recommendations March 25 2021]. [cited 2024 Jan 1]. Available from: https:\/\/www.sanidad.gob.es\/profesionales\/saludPublica\/prevPromocion\/vacunaciones\/programasDeVacunacion\/docs\/HerpesZoster_RecomendacionesVacunacion.pdf"},{"key":"e_1_3_7_118_1","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm6903a5"},{"key":"e_1_3_7_119_1","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines8030385"},{"key":"e_1_3_7_120_1","unstructured":"World Health Organization. Department of violence and injury prevention and disability. Prevention and management of wound infection. [cited 2024 Jan 1]. Available from: https:\/\/www.who.int\/hac\/techguidance\/tools\/guidelines_prevention_and_management_wound_infection.pdf"},{"key":"e_1_3_7_121_1","doi-asserted-by":"publisher","DOI":"10.1111\/ajt.12122"},{"key":"e_1_3_7_122_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2019.03.016"},{"key":"e_1_3_7_123_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/civ144"},{"key":"e_1_3_7_124_1","doi-asserted-by":"publisher","DOI":"10.2217\/fmb-2018-0026"},{"key":"e_1_3_7_125_1","doi-asserted-by":"publisher","DOI":"10.1080\/14760584.2017.1333906"},{"key":"e_1_3_7_126_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(21)00403-5"},{"key":"e_1_3_7_127_1","doi-asserted-by":"publisher","DOI":"10.4414\/smw.2015.14159"}],"container-title":["Expert Review of Vaccines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14760584.2024.2401839","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T09:46:34Z","timestamp":1759830394000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/14760584.2024.2401839"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,23]]},"references-count":125,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,12,31]]}},"alternative-id":["10.1080\/14760584.2024.2401839"],"URL":"https:\/\/doi.org\/10.1080\/14760584.2024.2401839","relation":{},"ISSN":["1476-0584","1744-8395"],"issn-type":[{"value":"1476-0584","type":"print"},{"value":"1744-8395","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,23]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ierv20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ierv20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2024-05-08","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-09-04","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-09-23","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}